https://www.selleckchem.com/pr....oducts/liproxstatin-
73 m ) and large tumor size (≥ 30mm) before BCG induction as independent poor prognostic factors for progression-free survival and overall survival, while the latter was also an independent factor for cancer-specific survival. The presence of variant histology was an independent poor prognostic factor for overall survival. The high-risk non-cystectomy group showed a significantly poor prognosis for progression-free survival (hazard ratio 7.61, 95% confidence interval 2.11-27.5), cancer-specific survival (10.4, 0.54-70.02), and ov
Like
Comment
Share
